950 related articles for article (PubMed ID: 11022966)
1. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
Witchel HJ; Hancox JC
Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
Antzelevitch C
J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of pro-arrhythmic risk of drugs due to QT interval prolongation by the HERG expression system].
Chachin M; Kurachi Y
Nihon Yakurigaku Zasshi; 2002 Jun; 119(6):345-51. PubMed ID: 12089906
[TBL] [Abstract][Full Text] [Related]
4. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
Vincent GM
Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
[TBL] [Abstract][Full Text] [Related]
5. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
Priori SG; Cantù F; Schwartz PJ
Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
[TBL] [Abstract][Full Text] [Related]
6. The inherited long QT syndrome: from ion channel to bedside.
Vincent GM; Timothy K; Fox J; Zhang L
Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
[TBL] [Abstract][Full Text] [Related]
7. Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current.
London B; Trudeau MC; Newton KP; Beyer AK; Copeland NG; Gilbert DJ; Jenkins NA; Satler CA; Robertson GA
Circ Res; 1997 Nov; 81(5):870-8. PubMed ID: 9351462
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice.
Babij P; Askew GR; Nieuwenhuijsen B; Su CM; Bridal TR; Jow B; Argentieri TM; Kulik J; DeGennaro LJ; Spinelli W; Colatsky TJ
Circ Res; 1998 Sep; 83(6):668-78. PubMed ID: 9742063
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions between two long-QT syndrome gene products, HERG and KCNE2, rationalized by in vitro and in silico analysis.
Mazhari R; Greenstein JL; Winslow RL; Marbán E; Nuss HB
Circ Res; 2001 Jul; 89(1):33-8. PubMed ID: 11440975
[TBL] [Abstract][Full Text] [Related]
10. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
Roy M; Dumaine R; Brown AM
Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
[TBL] [Abstract][Full Text] [Related]
11. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates.
Chevalier P; Rodriguez C; Bontemps L; Miquel M; Kirkorian G; Rousson R; Potet F; Schott JJ; Baró I; Touboul P
Cardiovasc Res; 2001 May; 50(2):386-98. PubMed ID: 11334843
[TBL] [Abstract][Full Text] [Related]
13. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
Sanguinetti MC; Jiang C; Curran ME; Keating MT
Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
[TBL] [Abstract][Full Text] [Related]
14. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
15. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
Swan H; Viitasalo M; Piippo K; Laitinen P; Kontula K; Toivonen L
J Am Coll Cardiol; 1999 Sep; 34(3):823-9. PubMed ID: 10483966
[TBL] [Abstract][Full Text] [Related]
16. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.
Ficker E; Thomas D; Viswanathan PC; Dennis AT; Priori SG; Napolitano C; Memmi M; Wible BA; Kaufman ES; Iyengar S; Schwartz PJ; Rudy Y; Brown AM
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1748-56. PubMed ID: 11009462
[TBL] [Abstract][Full Text] [Related]
17. The long QT syndromes: genetic basis and clinical implications.
Chiang CE; Roden DM
J Am Coll Cardiol; 2000 Jul; 36(1):1-12. PubMed ID: 10898405
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.
Kongsamut S; Kang J; Chen XL; Roehr J; Rampe D
Eur J Pharmacol; 2002 Aug; 450(1):37-41. PubMed ID: 12176106
[TBL] [Abstract][Full Text] [Related]
19. [Electropharmacological assessment of the risk of drug-induced long-QT syndrome using native cardiac cells and cultured cells expressing HERG channels].
Nakaya H
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):384-92. PubMed ID: 12835532
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia.
Sanguinetti MC; Curran ME; Spector PS; Keating MT
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2208-12. PubMed ID: 8700910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
